Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension

Journal of Hypertension

Volumn 27, Issue 8, 2009, Pages 1672-1678

  Mancia, Giuseppe ^a,b   Bombelli, Michele ^a   Facchetti, Rita ^a,c   Madotto, Fabiana ^a,c   Quarti Trevano, Fosca ^a   Grassi, Guido ^a,b   Sega, Roberto ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

Ambulatory blood pressure; Diabetes; Hypertension; Masked hypertension; White coat hypertension

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE;

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY MASS; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE COURSE; HOME MONITORING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MASKED HYPERTENSION; MULTIVARIATE ANALYSIS; ONSET AGE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SUSTAINED HYPERTENSION; WHITE COAT HYPERTENSION;

EID: 68449091366     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832be5f9     Document Type: Article

References (31)

1. Mancia G, Zanchetti A. White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? J Hypertens 1996; 14:1049-1052.
2. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood pressure monitoring. Task force V: white-coat hypertension. Blood Press Monit 1999; 4:333-341.
3. Messerli FH, Cotiga D. Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdis. J Am Coll Cardiol 2005; 46:516-517.
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
5. Ribeiro L, Gama G, Santos A, Asmar R, Martins L, Polónia J. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives. Blood Press Monit 2000; 5:11-17.
6. Silva JA, Barbosa L, Bertoquini S, Maldonado J, Polonia J. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients. Rev Port Cardiol 2004; 23:1533-1547.
7. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol 2005; 20:1151-1155.
8. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104:1385-1392.
9. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen JA. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 2005; 45:493-498.
10. Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S, et al. Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens 2006; 19:880-886.
11. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, et al. Target organ damage in 'white coat hypertension' and 'masked hypertension'. Am J Hypertens 2008; 21:393-399.
12. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white coat effect. Hypertension 1997; 29:1218-1224.
13. Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation 1999; 100:1071-1076.
14. Celis H, Staessen JA, Thijs L, Buntinx F, De Buyzere M, Den Hond E, et al. Cardiovascular risk in white-coat and sustained hypertensive patients. Blood Press 2002; 11:352-356.
15. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short-and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45:203-208.
16. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005; 19:801-807.
17. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853.
18. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegárd K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J Hypertens 2007; 25:1554-1564.
19. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007; 30:479-488.
20. Sowers JR, Epstein M, Frolich ED. Diabetes, hypertension and cardiovascular disease: an update. Hypertension 2001; 37:1053-1059.
21. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16:434-444.
22. Sega R, Cesana G, Milesi C, Grassi G, Zanchetti A, Mancia G. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension 1997; 30:1-6.
23. WHO-MONICA Project Principal Investigators. The World Health Organization Monica Project: a major international collaboration. J Clin Epidemiol 1998; 41:105-114.
24. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697-701.
25. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 2006; 29:1613-1618.
26. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW, Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002; 25:1845-1850.
27. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Quarti-Trevano F, et al. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens 2008; 26:1602-1611.
28. Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G, Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens 2008; 26:1891-1900.
29. Mancia G, Facchetti R, Bombelli M, Polo Friz H, Grassi G, Giannattasio C, Sega R. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005; 45:1072-1077.
30. Weber MA, Neutel JM, Smith DH, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90:2291-2298.
31. Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 2002; 20:1879-1886.